Stephan Stilgenbauer

27PUBLICATIONS
229CO-AUTHORS
Cancer geneticsAutoimmunityHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (27)

|Sep 24, 2026
In-frame variants in TP53 gene identified in adult leukemia samples are predominantly deleterious: a study of the TP53 Network of Education and Research Initiative on CLL.

|May 27, 2026
Autoantibodies to IL-1Ra and PGRN in severe COVID-19 are associated with inflammation-induced hyperphosphorylated antigen isoforms.

|Apr 23, 2026
The spectrum of immunoglobulin heavy chain enhancer hijacking in chronic lymphocytic leukemia.

|Mar 12, 2026
Short and complex-Telomeres and genomes in CLL.

Billy Michael Chelliah Jebaraj, Stephan Stilgenbauer

|Feb 26, 2026
Fitness beyond age: Multidisciplinary expert opinion on redefining fitness for targeted therapies in chronic lymphocytic leukemia.

Raúl Córdoba, Stephan Stilgenbauer, Paolo Ghia

|Feb 08, 2026
Overactivation of Cdc42 GTPase Impairs the Cytotoxic Function of NK Cells From Old Individuals Towards Senescent Fibroblasts.

Albert Kallon Koroma, Karmveer Singh, Yongfang Wang

Pageof 5

Frequent Collaborators

5 joint publications

Paolo Ghia

4 joint publications

Michael Hallek

3 joint publications

Othman Al-Sawaf

3 joint publications

Sébastien Hergalant